| Topic Name: |
Biotechnology |
| Message Name: |
WHAT's HOT FROM DOWN UNDER |
| Date Posted: |
05/21/2004 |
| Message: |
SCIENTISTS FROM AUSTRALIA AND NEW ZEALAND DISCUSS STEM CELL RESEARCH AND CLINICAL TRIALS AT 3rd ANNUAL CONFERENCE IN CAMBRIDGE, MASSACHUSETTS
Cambridge, MA, May 19, 2004 ?? Cutting-edge scientific areas such as stem cells and cellular treatments for cancer will be among the focus of discussion at the upcoming 3rd Annual Boston Bio-Relationships 2004 Conference, the region??s only American-Australian-New Zealand biopharmaceutical meeting, at the Royal Sonesta Hotel in Cambridge, Massachusetts on Wednesday, June 2, 2004. Keynote speakers include Jacky Vonderscher, Ph.D., Vice President and Global Head of Biomarker Development, Novartis Institutes for Biomedical Research.
??Not everyone is aware of the fact that remarkable scientific advances are being made ??down under?? in some of the most promising areas of biotechnology, including stem cell and oncology research,?? noted Ian Nisbet, Ph.D., Senior Director, Millennium Pharmaceuticals and Panel Chair. ??This conference is a rare opportunity in the US to meet first hand senior management and to learn about the science underway in one of the leading biotechnology hubs in the world.??
Alan Watson, Ph.D., M.B.A., Chief Business Officer of Elixir Pharmaceuticals and a conference Co-Chairman added, ??There is a highly favorable social and intellectual environment for rapidly advancing biotechnology in Australia and New Zealand. This has enabled the region??s academic institutions and entrepreneurial biotechnology companies to collaboratively approach many diseases with novel therapies in a non-conventional way.??
Conference presentations will address the benefits of conducting early stage clinical trials in Australia, as well as focus on the recent developments regarding the availability of hES cell lines, cellular treatments for cancer, hematopoietic stem cells, stem cell transformation, regenerative medicine and advances in diabetes.
Distinguished guest speakers at the conference will also include: John Wood, the New Zealand Ambassador to the United States; John Spasojevic, Minister Counselor for Industry, Tourism and Resources at the Australian Embassy Washington DC; Stephen Livesey, Ph.D., Chief Scientific Officer of The Australian National Stem Cell Centre; Richard Faull, Professor and Director, Neurological Foundation Brain Bank, University of Auckland; and Marcus Vowels, Ph.D., Professor and Head, Stem Cell Transplant Program and Director, Australian Cord Blood Bank.
Company speakers include senior management from Novotech Pty Ltd, Q-Pharm Pty Ltd, Beltas Ltd, The Brain Resource Company and Cambridge-based ViaCell.
For event details and registration, please visit www.biorelationships.com.
About Boston Bio-Relationships
Boston Bio-Relationships is a high-level biopharmaceutical business meeting that connects business executives from Australia, New Zealand and the USA. For more information and to register for the conference, please visit www. Biorelationships.com.
|
|
